Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.sutrobio.com save search
Sutro Biopharma Announces Departure of Chief Medical Officer
Published: 2022-10-24 (Crawled : 11:00) - sutrobio.com
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 70.8%
H: 2.7%
C: -6.12%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 0.71%
H: 14.96%
C: 13.91%
biopharma
Sutro Biopharma to Participate in Three Upcoming Investor Conferences
Published: 2021-11-02 (Crawled : 12:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 5.25%
H: 3.65%
C: 3.28%
biopharma conference
41st Annual JP Morgan Healthcare Conference – Presentation
Published: 2023-01-12 (Crawled : 19:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 5.08%
H: 4.22%
C: -2.36%
conference presentation
Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer
Published: 2021-12-27 (Crawled : 12:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 5.05%
H: 2.02%
C: -2.67%
stro-002 treatment biopharma expansion drug ovarian cancer cancer antibody
Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China
Published: 2021-12-27 (Crawled : 12:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 5.05%
H: 2.02%
C: -2.67%
stro-002 als biopharma license china
Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract
Published: 2022-12-20 (Crawled : 22:00) - sutrobio.com
PPRUF | News | $361.9 37.56% 4.3K
|
Consumer Non-Durables
|
| O: 2.83%
H: 2.66%
C: -0.36%
PPRUY | News | $36.03 -0.11% 330K
|
Manufacturing
|
| O: 1.46%
H: 1.58%
C: 0.82%
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.22%
H: 3.45%
C: 3.2%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.79%
H: 1.43%
C: 0.0%
biopharma grant agreement
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
Published: 2022-12-21 (Crawled : 13:00) - sutrobio.com
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: 0.22%
H: 3.45%
C: 3.2%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.79%
H: 1.43%
C: 0.0%
stro-002 biopharma update cancer ovarian cancer
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
Published: 2022-05-09 (Crawled : 21:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.57%
H: 5.99%
C: 1.33%
biopharma
Bill Newell, CEO Interviewed by Dr. Michelle McMurry-Heath on I Am Bio Podcast, Episode 73 – “Investors Become Goldilocks in a Bear Market”
Published: 2022-06-02 (Crawled : 21:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.18%
H: 0.0%
C: 0.0%
ceo
Senior Process Engineer, MSAT
Published: 2021-06-17 (Crawled : 18:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 4.0%
H: 4.31%
C: 2.26%
63rd American Society of Hematology (ASH) Annual Meeting and Exposition – Non-Audio Presentation
Published: 2022-01-11 (Crawled : 17:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 3.6%
H: 0.0%
C: 0.0%
Sutro Biopharma Reports Second Quarter 2021 Financial Results, Business Highlights and Anticipated Second Half 2021 Milestones
Published: 2021-08-09 (Crawled : 11:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 3.25%
H: 2.88%
C: -0.27%
biopharma financial results results milestone
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Published: 2021-08-09 (Crawled : 11:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 3.25%
H: 2.88%
C: -0.27%
biopharma commercialization
Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
Published: 2022-03-03 (Crawled : 12:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 2.91%
H: 0.0%
C: -6.0%
health biopharma thc conference
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Published: 2023-01-09 (Crawled : 22:00) - sutrobio.com
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -0.3%
H: 1.79%
C: 0.35%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 biopharma update cancer study ovarian cancer phase 1
Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation
Published: 2023-01-09 (Crawled : 23:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.93%
H: 0.89%
C: -14.08%
stro-002 program trial presentation update cancer ovarian cancer
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Published: 2022-11-08 (Crawled : 22:00) - sutrobio.com
PCVX | $60.65 -2.85% -2.93% 660K
|
Health Technology
|
| O: -1.05%
H: 2.21%
C: -2.28%
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.82%
H: 4.67%
C: 0.82%
biopharma financial
Credit Suisse 31st Annual Healthcare Conference – Presentation
Published: 2022-11-09 (Crawled : 12:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.82%
H: 4.67%
C: 0.82%
conference presentation
Senior Accountant
Published: 2021-04-14 (Crawled : 22:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.81%
H: 8.31%
C: 5.28%
Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck
Published: 2021-04-15 (Crawled : 11:00) - sutrobio.com
STRO M | $3.76 -1.05% -1.06% 770K
|
Health Technology
|
| O: 1.81%
H: 8.31%
C: 5.28%
biopharma collaboration milestone
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.